Skip to main content

Advertisement

Log in

Tuberculosis in Indigenous Persons — United States, 2009–2019

  • Published:
Journal of Racial and Ethnic Health Disparities Aims and scope Submit manuscript

Abstract

Background

Populations of indigenous persons are frequently associated with pronounced disparities in rates of tuberculosis (TB) disease compared to co-occurring nonindigenous populations.

Methods

Using data from the National Tuberculosis Surveillance System on TB cases in U.S.-born patients reported in the United States during 2009–2019, we calculated incidence rate ratios and risk ratios for TB risk factors to compare cases in American Indian or Alaska Native (AIAN) and Native Hawaiian or other Pacific Islander (NHPI) TB patients to cases in White TB patients.

Results

Annual TB incidence rates among AIAN and NHPI TB patients were on average ≥10 times higher than among White TB patients. Compared to White TB patients, AIAN and NHPI TB patients were 1.91 (95% confidence interval (CI): 1.35–2.71) and 3.39 (CI: 1.44–5.74) times more likely to have renal disease or failure, 1.33 (CI: 1.16–1.53) and 1.63 (CI: 1.20–2.20) times more likely to have diabetes mellitus, and 0.66 (CI: 0.44–0.99) and 0.19 (CI: 0–0.59) times less likely to be HIV positive, respectively. AIAN TB patients were 1.84 (CI: 1.69–2.00) and 1.48 (CI: 1.27–1.71) times more likely to report using excess alcohol and experiencing homelessness, respectively.

Conclusion

TB among U.S. indigenous persons is associated with persistent and concerning health disparities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Tollefson D, Bloss E, Fanning A, Redd J, Barker K, McCray E. Burden of tuberculosis in indigenous peoples globally: a systematic review. Int J Tuberc Lung D. 2013;17(9):1139–50.

    Article  CAS  Google Scholar 

  2. Hixson L, Helper BB, Kim MO. The Native Hawiian and other Pacific Islander population: 2010. U.S. Department of Commerce, Economics and Statistics Administration, U.S. Census Bureau. 2012;C2010BR-12. https://www.census.gov/prod/cen2010/briefs/c2010br-12.pdf.

  3. Norris T, Vines PL, Hoeffel EM. The American Indian and Alaska Native population: 2010. U.S. Department of Commerce, Economics and Statistics Administration, U.S. Census Bureau. 2012;C2010BR-10. https://www.census.gov/prod/cen2010/briefs/c2010br-10.pdf.

  4. U.S. Census Bureau. Table DP05, 2019 American Community Survey (ACS) 5-year estimates. https://data.census.gov/cedsci/. Accessed 14 Jan 2021.

  5. Schneider E. Tuberculosis among American Indians and Alaska Natives in the United States, 1993–2002. Am J Public Health. 2005;95(5):873–80.

    Article  Google Scholar 

  6. Bloss E, Holtz TH, Jereb J, Redd JT, Podewils LJ, Cheek JE, et al. Tuberculosis in indigenous peoples in the U.S., 2003–2008. Public Health Rep. 2011;126(5):677–89.

    Article  Google Scholar 

  7. U.S. Centers for Disease Control and Prevention. Reported tuberculosis in the United States, 2019. Atlanta, GA: U.S. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services. 2020. https://www.cdc.gov/tb/statistics/reports/2019/default.htm.

  8. Cheek JE, Holman RC, Redd JT, Haberling D, Hennessy TW. Infectious disease mortality among American Indians and Alaska Natives, 1999–2009. Am J Public Health. 2014;104(S3):S446–52.

    Article  Google Scholar 

  9. Reilley B, Bloss E, Byrd KK, Iralu J, Neel L, Cheek J. Death rates from human immunodeficiency virus and tuberculosis among American Indians/Alaska Natives in the United States, 1990–2009. Am J Public Health. 2014;104(S3):S453–9.

    Article  Google Scholar 

  10. Holman RC, Folkema AM, Singleton RJ, Redd JT, Christensen KY, Steiner CA, et al. Disparities in infectious disease hospitalizations for American Indian/Alaska Native people. Public Health Rep. 2011;126(4):508–21.

    Article  Google Scholar 

  11. Marks S, Magee E, Robison V. Patients diagnosed with tuberculosis at death or who died during therapy: association with the human immunodeficiency virus. Int J Tuberc Lung D. 2011;15(4):465–70.

    Article  CAS  Google Scholar 

  12. Santosham M, Reid R, Chandran A, Millar EV, Watt JP, Weatherholtz R, et al. Contributions of Native Americans to the global control of infectious diseases. Vaccine. 2007;25(13):2366–74.

    Article  Google Scholar 

  13. Townsend J, Aronson JD, Saylor R, Parr I. Tuberculosis control among the North American Indians. Am Rev Tuberc Pulm. 1942;45(1):41–52.

    Google Scholar 

  14. Aronson NE, Santosham M, Comstock GW, Howard RS, Moulton LH, Rhoades ER, et al. Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: a 60-year follow-up study. J Amer Med Assoc. 2004;291(17):2086–91.

    Article  CAS  Google Scholar 

  15. Comstock G, Baum C, Snider DE Jr. Isoniazid prophylaxis among Alaskan Eskimos: a final report of the Bethel isoniazid studies. Am Rev Respir Dis. 1979;119(5):827–30.

    CAS  PubMed  Google Scholar 

  16. Jones DS. The health care experiments at Many Farms: The Navajo, tuberculosis, and the limits of modern medicine, 1952–1962. B Hist Med. 2002;76(4):749–90.

    Article  Google Scholar 

  17. France AM, Grant J, Kammerer JS, Navin TR. A field-validated approach using surveillance and genotyping data to estimate tuberculosis attributable to recent transmission in the United States. Am J Epidemiol. 2015;182(9):799–807.

    Article  Google Scholar 

  18. U.S. Centers for Disease Control and Prevention. Report of verified case of tuberculosis (RVCT) in the United States. Atlanta, GA: U.S. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services. 2003. https://www.cdc.gov/tb/programs/rvct/default.htm

  19. Ghosh S, Moonan PK, Cowan L, Grant J, Kammerer S, Navin TR. Tuberculosis genotyping information management system: enhancing tuberculosis surveillance in the United States. Infect Genet Evol. 2012;12(4):782–8.

    Article  Google Scholar 

  20. Li C, Ford ES, Zhao G, Wen XJ, Gotway CA. Age adjustment of diabetes prevalence: use of 2010 U.S. Census data. J Diabetes. 2014;6(5):451–61.

    Article  Google Scholar 

  21. U.S. Office of Management and Budget. Circular A-105: Standard Federal Regions. Executive Office of the President, Office of Management and Budget. 1974.

  22. Hannah HA, Miramontes R, Gandhi NR. Sociodemographic and clinical risk factors associated with tuberculosis mortality in the United States, 2009–2013. Public Health Rep. 2017;132(3):366–75.

    Article  Google Scholar 

  23. Okada RC, Barry PM, Skarbinski J, Chitnis AS. Epidemiology, detection, and management of tuberculosis among end-stage renal disease patients. Infect Cont Hosp Ep. 2018;39(11):1367–74.

    Article  Google Scholar 

  24. Armstrong LR, Kammerer JS, Haddad MB. Diabetes mellitus among adults with tuberculosis in the USA, 2010–2017. BMJ Open Diabetes Res Care. 2020;8(1):e001275.

    Article  Google Scholar 

  25. Baker MA, Harries AD, Jeon CY, Hart JE, Kapur A, Lönnroth K, et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med. 2011;9(81):1–15.

    Google Scholar 

  26. Jiménez-Corona ME, Cruz-Hervert LP, García-García L, Ferreyra-Reyes L, Delgado-Sánchez G, Bobadilla-del-Valle M, et al. Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes. Thorax. 2013;68(3):214–20.

    Article  Google Scholar 

  27. Oeltmann JE, Kammerer JS, Pevzner ES, Moonan PK. Tuberculosis and substance abuse in the United States, 1997–2006. Arch Intern Med. 2009;169(2):189–97.

    Article  Google Scholar 

  28. Rehm J, Samokhvalov AV, Neuman MG, Room R, Parry C, Lönnroth K, et al. The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review. BMC Public Health. 2009;9(450):1–12.

    Google Scholar 

  29. Volkmann T, Moonan P, Miramontes R, Oeltmann J. Tuberculosis and excess alcohol use in the United States, 1997–2012. Int J Tuberc Lung D. 2015;19(1):111–9.

    Article  CAS  Google Scholar 

  30. Bamrah S, Yelk Woodruff R, Powell K, Ghosh S, Kammerer J, Haddad M. Tuberculosis among the homeless, United States, 1994–2010. Int J Tuberc Lung D. 2013;17(11):1414–9.

    Article  CAS  Google Scholar 

  31. Hargreaves JR, Boccia D, Evans CA, Adato M, Petticrew M, Porter JD. The social determinants of tuberculosis: from evidence to action. Am J Public Health. 2011;101(4):654–62.

    Article  Google Scholar 

  32. Lönnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med. 2009;68(12):2240–6.

    Article  Google Scholar 

  33. Pindus N, Kingsley T, Biess J, Levy D, Simington J, Hayes C. Housing needs of American Indians and Alaska Natives in tribal areas: a report from the assessment of American Indian, Alaska Native, and Native Hawaiian housing needs. U.S. Department of Housing Urban Development, Office of Policy Development Research. 2017. https://www.huduser.gov/portal/sites/default/files/pdf/HNAIHousingNeeds.pdf.

  34. Humes KR, Jones NA, Ramirez RR. Overview of race and Hispanic origin: 2010. U.S. Department of Commerce, Economics and Statistics Administration, U.S. Census Bureau. 2011;C2010BR-02. https://www.census.gov/prod/cen2010/briefs/c2010br-02.pdf.

  35. Jones NA, Bullock J. The two or more races population: 2010. U.S. Department of Commerce, Economics and Statistics Administration, U.S. Census Bureau. 2012;C2010BR-13. https://www.census.gov/prod/cen2010/briefs/c2010br-13.pdf.

  36. U.S. Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2020. Atlanta, GA: U.S. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services. 2020. https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf.

  37. McElfish PA, Purvis RS, Esquivel MK, Sinclair KA, Townsend C, Hawley NL, et al. Diabetes disparities and promising interventions to address diabetes in Native Hawaiian and Pacific Islander populations. Curr Diabetes Rep. 2019;19(5):1–9.

    Article  Google Scholar 

  38. Eisinger RW, Embry AC, Read SW, Fauci AS. 2019: a banner year for tuberculosis research. J Infect Dis. 2020;222(11):1768–71.

    Article  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Andrew N. Hill, Robert H. Pratt, Julie L. Self, and Clarisse A. Tsang for assistance with data management and analysis.

Funding

This work was funded by the U.S. Centers for Disease Control and Prevention.

Author information

Authors and Affiliations

Authors

Contributions

Adam J. Langer and Yuri P. Springer conceived the investigation. Yuri P. Springer and J. Steve Kammerer completed the analyses. Yuri P. Springer and Benjamin J. Silk led the writing. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Yuri P. Springer.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Disclaimer

The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the U.S. Centers for Disease Control and Prevention.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Online Resource 1

Crude annual tuberculosis (TB) case rates (per 100,000 persons) by race/ethnicity among U.S.-born persons: United States, 2009–2019. Associated case counts, population estimates, and incidence rate ratios (using the White race/ethnicity group as the reference) are also provided. (XLSX 17 kb)

Online Resource 2

Age-adjusted annual tuberculosis (TB) case rates (per 100,000 persons) by race/ethnicity among U.S.-born persons: United States, 2009–2019. AIAN = American Indian or Alaska Native; NHPI = Native Hawaiian or other Pacific Islander. (PDF 7 kb)

Online Resource 3

Age-adjusted annual tuberculosis (TB) case rates (per 100,000 persons) by race/ethnicity among U.S.-born persons: United States, 2009–2019. Associated case count estimates and incidence rate ratios (using the White race/ethnicity group as the reference) are also provided. (XLSX 16 kb)

Online Resource 4

Characteristics of tuberculosis (TB) cases in patients aged ≥15 years attributed to recent transmission, by race/ethnicity among U.S.-born persons: United States, 2011–2019. (XLSX 17 kb)

Online Resource 5

Annual counts of and rate-related statistics for tuberculosis (TB) cases in patients aged ≥15 years attributed to recent transmission, by race/ethnicity among U.S.-born persons: United States, 2011–2019. ( 15 kb)

Online Resource 6

Annual population estimates from the U.S. Census Bureau’s American Community Survey (ACS) used to derive denominators for calculation of crude annual tuberculosis (TB) case rates (per 100,000 persons) by race/ethnicity. (XLSX 17.7 kb)

Online Resource 7

Age-stratified annual population estimates from the U.S. Census Bureau’s American Community Survey (ACS) used to derive denominators for calculation of age-adjusted annual tuberculosis (TB) case rates (per 100,000 persons) by race/ethnicity. (XLSX 92.7 kb)

Online Resource 8

Denominators used for calculation of crude and age-adjusted annual tuberculosis (TB) case rates (per 100,000) by race/ethnicity. Age-stratified counts for the 2010 United States standard population are also provided. (XLSX 17.5 kb)

Appendices

Appendix 1

Population data for rate calculations were obtained from the U.S. Census Bureau’s American Community Survey (ACS) through queries of the Census Bureau website (data.census.gov/mdat) on January 14, 2021. These data are provided in Online Resources 6, 7 and 8 for reference.

Crude annual TB case rate calculations:

To calculate crude annual TB case rates (per 100,000 persons) by patient race/ethnicity group, we obtained annual population estimates from the public use microdata sample (PUMS), 5-year population estimates using queries involving the RAC1P, RAC2P, RAC2P12, RAC3P, HISP, and NATIVITY variables and person-weight weighting as follows:

  1. A.

    For the AIAN, Asian, Black, and White groups, we obtained annual population estimates using queries involving the RAC1P, HISP, and NATIVITY variables (e.g., https://data.census.gov/mdat/#/search?ds=ACSPUMS5Y2019&cv=NATIVITY(1),HISP(01)&rv=RAC1P&wt=PWGTP). For the HISP and NATIVITY variables, we only included counts associated with the “Not Spanish/Hispanic/Latino” and “Native” categories, respectively. For the AIAN group, we summed counts associated with three RAC1P categories (“American Indian alone,” “Alaska Native alone,” and “American Indian and Alaska Native tribes specified; or American Indian or Alaska Native, not specified and no other race”) to generate the population estimate for each year.

  2. B.

    For the Hispanic group, we obtained annual population estimates using queries involving the HISP and NATIVITY variables (e.g., https://data.census.gov/mdat/#/search?ds=ACSPUMS5Y2019&cv=NATIVITY(1)&rv=HISP(02,03,04,05,06,07, 08,09,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24)&wt=PWGTP). For the HISP variable, we included counts associated with all categories except “Not Spanish/Hispanic/Latino.” For the NATIVITY variable, we only included counts in the “Native” category. We summed counts associated with all 23 HISP categories to generate the population estimate for each year.

  3. C.

    For the NHPI group, we obtained annual population estimates using queries involving the RAC1P, RAC2P, RAC2P12, RAC3P, HISP, and NATIVITY variables. We did this as follows to obtain estimates as consistent as possible with our NHPI TB case definition, which excluded some NHPI subraces:

    1. i.

      For years 2016–2019, we first obtained annual population estimates using queries involving the RAC2P, HISP, and NATIVITY variables (e.g., https://data.census.gov/mdat/#/search?ds=ACSPUMS5Y2019&cv=NATIVITY(1),HISP(01)&rv=RAC2P(60,61,62,63,64,65,66)&wt=PWGTP). For the RAC2P variable, we included counts associated with all seven NHPI-related categories (i.e., NHPI subraces): “Native Hawaiian alone,” “Samoan alone,” “Tongan alone,” “Guamanian or Chamorro alone,” “Marshallese alone,” “Fijian alone,” and “Other Native Hawaiian and Other Pacific Islander.” For the HISP and NATIVITY variables, we only included counts associated with the “Not Spanish/Hispanic/Latino” and “Native” categories, respectively. Next, we compared these annual population estimates to those obtained for the “Native Hawaiian and Other Pacific Islander alone” category using the queries involving the RAC1P, HISP, and NATIVITY variables (described above in section 1A). The population estimates generated using the RAC2P queries and the RAC1P queries were the same in each of the four years during 2016–2019. Given this concordance, we summed the counts associated with the three RAC2P categories that we sought to exclude from our NHPI population estimates (“Tongan alone,” “Marshallese alone,” “Fijian alone”) in each year during 2016–2019 and subtracted that sum from the population estimate obtained using the RAC1P query for that year.

    2. ii.

      For years 2012–2015, we first obtained annual population estimates using queries involving the RAC2P12, HISP, and NATIVITY variables (e.g., https://data.census.gov/mdat/#/search?ds=ACSPUMS5Y2015&cv=NATIVITY(1),HISP(01)&rv=RAC2P12(60,61,62,63,64,65,66)&wt=PWGTP). For the RAC2P12 variable, we included counts associated with all seven NHPI-related categories (i.e., NHPI subraces): “Native Hawaiian alone,” “Samoan alone,” “Tongan alone,” “Guamanian or Chamorro alone,” “Marshallese alone,” “Fijian alone”, and “Other Native Hawaiian and Other Pacific Islander.” For the HISP and NATIVITY variables, we only included counts associated with the “Not Spanish/Hispanic/Latino” and “Native” categories, respectively. Next, we compared these annual population estimates to those obtained for the “Native Hawaiian and Other Pacific Islander alone” category using the queries involving the RAC1P, HISP, and NATIVITY variables (described above in section 1A). The population estimates generated using the RAC2P12 queries and the RAC1P queries were different in each year during 2012–2015. Given this discordance, we summed the counts associated with the three RAC2P12 (or RAC2P) categories that we sought to exclude from our NHPI population estimates (“Tongan alone,” “Marshallese alone,” “Fijian alone”) in each year during 2012–2019 and quantified the percent of the total population estimate obtained using the RAC2P12 (or RAC2P) query that this sum represented. For each of the three categories that we sought to exclude, these percentages were highly consistent across the seven years (mean+stdev: “Tongan alone” = 5.77%±0.37%, “Marshallese alone” = 2.48%±0.42%, “Fijian alone” = 2.76%±0.19%). Given this consistency we summed the counts associated with the three RAC2P12 categories that we sought to exclude in each year during 2012–2015, calculated the percent of the total population estimated using the RAC2P12 query that this represented, and then reduced the population estimate obtained using the RAC1P query for that year proportionally.

    3. iii.

      For years 2009–2011, we first obtained annual population estimates using queries involving the RAC3P, HISP, and NATIVITY variables (e.g., https://data.census.gov/mdat/#/search?ds=ACSPUMS5Y2011&cv=NATIVITY(1),HISP(01)&rv=RAC3P(02,03,04,05,06)&wt=PWGTP). For the RAC3P variable, we included counts associated with all five NHPI-related categories (i.e., NHPI subraces): “Native Hawaiian alone,” “Samoan alone,” “Guamanian or Chamorro alone,” “Other Pacific Islander alone,” and “Native Hawaiian and Other Pacific Islander groups only.” For the HISP and NATIVITY variables, we only included counts associated with the “Not Spanish/Hispanic/Latino” and “Native” categories, respectively. Next, we compared these annual population estimates to those obtained for the “Native Hawaiian and Other Pacific Islander alone” category using the queries involving the RAC1P, HISP, and NATIVITY variables (described above in section 1A). The population estimates generated using the RAC3P queries and the RAC1P queries were the same in each year during 2009–2011, but counts for the three NHPI subrace categories that we sought to exclude from our NHPI population estimates (“Tongan alone,” “Marshallese alone,” “Fijian alone”) were not reported separately. Given the aforementioned interannual consistency in the percent of the annual total population estimate associated with counts for these three NHPI subrace categories during 2012–2019, we summed the three percentages in each year during 2012–2019 (range=10.4–11.4%), averaged these sums across years (mean+stdev: 11.02%±0.003%), rounded this average to the nearest whole percent (11%), and reduced the population estimate obtained using the RAC1P query for each year during 2009–2011 by that proportion.

Age-adjusted annual TB case rate calculations:

To calculate age-adjusted annual TB case rates (per 100,000 persons) by patient race/ethnicity group, we used the direct method, the 2010 U.S. Standard population, and age-stratified annual population estimates from the U.S. Census Bureau’s American Community Survey (ACS). We applied the six-level age categorization scheme used in NTSS: <5 years, 5–14 years, 15–24 years, 25–44 years, 45–64 years, and ≥65 years.

The 2010 U.S. standard population (308,745,538 persons), as estimated using 2010 decennial census data from the U.S. Census Bureau, was partitioned into the six NTSS age categories based on published age-stratified counts [20] as follows: <5 years=20,201,362 persons; 5–14 years=41,025,851 persons; 15–24 years=43,626,342 persons; 25–44 years=82,134,554 persons; 45–64 years=81,489,445 persons; ≥65 years=40,267,984 persons.

We obtained age-stratified annual population estimates from the public use microdata sample (PUMS), 5-year population estimates using queries involving the RAC1P, HISP, NATIVITY, and AGEP variables and person-weight weighting as follows:

  1. A.

    For the AIAN, NHPI, Asian, Black, and White groups, we obtained age-stratified annual population estimates using queries involving the RACE1P, HISP, NATIVITY, and AGEP variables (e.g., https://data.census.gov/mdat/#/search?ds=ACSPUMS5Y2019&cv=NATIVITY(1),HISP(01),RAC1P&rv=AGEP&wt=PWGTP). For the HISP and NATIVITY variables, we only included counts associated with the “Not Spanish/Hispanic/Latino” and “Native” categories, respectively. For the AIAN group, we summed counts associated with three RAC1P categories (“American Indian alone,” “Alaska Native alone,” and “American Indian and Alaska Native tribes specified; or American Indian or Alaska Native, not specified and no other race”) to generate the population estimate for each year.

  2. B.

    For the Hispanic group, we obtained age-stratified annual population estimates using queries involving the HISP, NATIVITY, and AGEP variables (e.g., https://data.census.gov/mdat/#/search?ds=ACSPUMS5Y2019&cv=NATIVITY(1),HISP(02,03,04,05,06,07, 08,09,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24)&rv=AGEP&wt=PWGTP). For the HISP variable, we included counts associated with all categories except “Not Spanish/Hispanic/Latino.” For the NATIVITY variable we only included counts in the “Native” category. We summed counts associated with all 23 HISP categories to generate the population estimate for each year.

  3. C.

    For the NHPI group, age-stratified counts were not available for the annual population estimates obtained using the queries involving the RAC1P, RAC2P, RAC2P12, RAC3P, HISP, and NATIVITY variables (described above in section 1C). To approximate these, we obtained age-stratified annual population estimates for the “Native Hawaiian and Other Pacific Islander alone” category using queries involving the RACE1P, HISP, NATIVITY, and AGEP variables (described above in section 2A) and used these to determine the percent of the total population associated with each of the 6 NTSS age categories. We then calculated the products of these percentages and the annual population estimates obtained using the queries involving the RAC1P, RAC2P, RAC2P12, RAC3P, HISP, and NATIVITY variables to complete the age-stratified approximations.

Appendix 2

Among incident TB cases with a count date during January 1, 2009–December 31, 2019, counted within any of the 50 states or DC, and in a patient classified as being U.S.-born and who reported their race/ethnicity as AIAN, NHPI (or both), 332 were not classified into either the AIAN or the NHPI patient race/ethnicity group because they met one of the follow criteria:

  1. A.

    A total of 106 cases were classified into the Multiple/unknown patient race/ethnicity group because they were in patients who reported their race as AIAN or NHPI (or both) and one or more other races (i.e., multiple race/ethnicity). Of these, 76 were in patients who reported their race as AIAN and another race other than NHPI (the most common other races reported by these patients were White (57) and Black (21)), 28 were in patients who reported their race as NHPI and another race other than AIAN (the most common other races reported by these patients were White (16) and Asian (11)), and 2 were in patients who reported their race as AIAN and NHPI.

  2. B.

    A total of 9 cases were classified into the Multiple/unknown patient race/ethnicity group because they were in patients who did not self-report their ethnicity (i.e., unknown race/ethnicity). Of these, 7 reported their race as AIAN, 1 reported their race as NHPI, and 1 reported their race as both AIAN and NHPI.

  3. C.

    A total of 63 cases were classified into the Hispanic patient race/ethnicity group because they were in patients who reported their ethnicity as Hispanic. Of these, 58 were in patients who reported their race as AIAN, 4 were in patients who reported their race as NHPI, and 1 was in a patient who reported their race as both AIAN and NHPI.

A total of 154 cases were excluded from the analysis entirely because they were in patients who reported a country of birth or an NHPI subrace (or both) not included in our AIAN and NHPI case definitions. Of these, 2 were in patients who reported their race as AIAN and their country of birth as France or India (these patients were likely misreported as AIAN); the remaining 152 were in patients who reported their race as NHPI. These 152 cases were in patients who reported their NHPI subrace and country of birth as follows: 52 Micronesian (of which 23 and 20 reported their country of birth as the United States or the Federated States of Micronesia, respectively), 47 Marshallese (of which 26 and 18 reported their country of birth as the United States or the Marshall Islands, respectively), 19 Chuukese (of which 10 reported their country of birth as the United States), 16 Tongan (of which 15 reported their country of birth as the United States), 4 Samoan, 1 Carolinian, 1 Fijian, 1 Solomon Islander, and 11 cases in patients who did not self-report an NHPI subrace (of which 8, 2, and 1 reported their country of birth as the Marshall Islands, Federated States of Micronesia, or Palau, respectively).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Springer, Y.P., Kammerer, J.S., Silk, B.J. et al. Tuberculosis in Indigenous Persons — United States, 2009–2019. J. Racial and Ethnic Health Disparities 9, 1750–1764 (2022). https://doi.org/10.1007/s40615-021-01112-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40615-021-01112-6

Keywords

Navigation